Gayatinea, Baby Boy M.
HRN: 21-65-43 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/31/2022
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/31/2022
01/07/2023
PO
3ml
Tid
İnfectious Diarrhea
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes